AEE Quote, Financials, Valuation and Earnings

Entergy has a net margin of 13.78% compared to Ameren's net margin of 12.73%. Ameren's return on equity of 10.12% beat Entergy's return on equity of 9%.

Ameren has a consensus price target of $102.70, signalling upside risk potential of 8.09%. On the other hand Entergy has an analysts' consensus of $89.26 which suggests that it could grow by 10.86%. Given that Entergy has higher upside potential than Ameren, analysts believe Entergy is more attractive than Ameren.

Ameren has a beta of 0.511, which suggesting that the stock is 48.881% less volatile than S&P 500. In comparison Entergy has a beta of 0.621, suggesting its less volatile than the S&P 500 by 37.924%.

Ameren has a quarterly dividend of $0.71 per share corresponding to a yield of 2.86%. Entergy offers a yield of 2.94% to investors and pays a quarterly dividend of $0.60 per share. Ameren pays 60.41% of its earnings as a dividend. Entergy pays out 94.23% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ameren quarterly revenues are $2.1B, which are smaller than Entergy quarterly revenues of $2.8B. Ameren's net income of $289M is lower than Entergy's net income of $362.4M. Notably, Ameren's price-to-earnings ratio is 21.07x while Entergy's PE ratio is 26.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ameren is 3.23x versus 2.93x for Entergy. Usually stocks with elevated PS ratios are considered overvalued.

Exelon has a net margin of 13.78% compared to Ameren's net margin of 13.52%. Ameren's return on equity of 10.12% beat Exelon's return on equity of 10.16%.

Ameren has a consensus price target of $102.70, signalling upside risk potential of 8.09%. On the other hand Exelon has an analysts' consensus of $47.03 which suggests that it could grow by 11.32%. Given that Exelon has higher upside potential than Ameren, analysts believe Exelon is more attractive than Ameren.

Ameren has a beta of 0.511, which suggesting that the stock is 48.881% less volatile than S&P 500. In comparison Exelon has a beta of 0.437, suggesting its less volatile than the S&P 500 by 56.261%.

Ameren has a quarterly dividend of $0.71 per share corresponding to a yield of 2.86%. Exelon offers a yield of 3.69% to investors and pays a quarterly dividend of $0.40 per share. Ameren pays 60.41% of its earnings as a dividend. Exelon pays out 61.95% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ameren quarterly revenues are $2.1B, which are smaller than Exelon quarterly revenues of $6.7B. Ameren's net income of $289M is lower than Exelon's net income of $908M. Notably, Ameren's price-to-earnings ratio is 21.07x while Exelon's PE ratio is 15.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ameren is 3.23x versus 1.79x for Exelon. Usually stocks with elevated PS ratios are considered overvalued.

NiSource has a net margin of 13.78% compared to Ameren's net margin of 21.75%. Ameren's return on equity of 10.12% beat NiSource's return on equity of 8.44%.

Ameren has a consensus price target of $102.70, signalling upside risk potential of 8.09%. On the other hand NiSource has an analysts' consensus of $42.63 which suggests that it could grow by 12.55%. Given that NiSource has higher upside potential than Ameren, analysts believe NiSource is more attractive than Ameren.

Ameren has a beta of 0.511, which suggesting that the stock is 48.881% less volatile than S&P 500. In comparison NiSource has a beta of 0.534, suggesting its less volatile than the S&P 500 by 46.601%.

Ameren has a quarterly dividend of $0.71 per share corresponding to a yield of 2.86%. NiSource offers a yield of 2.88% to investors and pays a quarterly dividend of $0.28 per share. Ameren pays 60.41% of its earnings as a dividend. NiSource pays out 64.34% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ameren quarterly revenues are $2.1B, which are smaller than NiSource quarterly revenues of $2.2B. Ameren's net income of $289M is lower than NiSource's net income of $474.8M. Notably, Ameren's price-to-earnings ratio is 21.07x while NiSource's PE ratio is 20.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ameren is 3.23x versus 2.95x for NiSource. Usually stocks with elevated PS ratios are considered overvalued.

Vistra has a net margin of 13.78% compared to Ameren's net margin of -6.81%. Ameren's return on equity of 10.12% beat Vistra's return on equity of 36.03%.

Ameren has a consensus price target of $102.70, signalling upside risk potential of 8.09%. On the other hand Vistra has an analysts' consensus of $163.94 which suggests that it could grow by 5.77%. Given that Ameren has higher upside potential than Vistra, analysts believe Ameren is more attractive than Vistra.

Ameren has a beta of 0.511, which suggesting that the stock is 48.881% less volatile than S&P 500. In comparison Vistra has a beta of 1.163, suggesting its more volatile than the S&P 500 by 16.258%.

Ameren has a quarterly dividend of $0.71 per share corresponding to a yield of 2.86%. Vistra offers a yield of 0.57% to investors and pays a quarterly dividend of $0.22 per share. Ameren pays 60.41% of its earnings as a dividend. Vistra pays out 17.98% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ameren quarterly revenues are $2.1B, which are smaller than Vistra quarterly revenues of $3.9B. Ameren's net income of $289M is higher than Vistra's net income of -$268M. Notably, Ameren's price-to-earnings ratio is 21.07x while Vistra's PE ratio is 24.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ameren is 3.23x versus 2.98x for Vistra. Usually stocks with elevated PS ratios are considered overvalued.